NZ BIOTECH FIRM TAKES CANCER TEST TO EUROPE

A new licensing deal with a German diagnostic firm could see a cancer test developed by Dunedin-based Pacific Edge Biotechnology hit a market worth millions in a year. The New Zealand Herald (http://www.nzherald.co.nz/category/story.cfm?c_id=204&objectid=10403834)